Search results for "TotalSeq"

FREEDOM study evaluates progesterone delivery using Callavid platform for threatened miscarriage

Elecsys pTau217 is the first single-assay blood test designed to identify or rule out amyloid pathology across primary and secondary care

Study demonstrates how RNA‑based analysis could enable early prediction of clinical outcomes across multiple conditions

Hear how the Program of Glyco-Immunology and Oncology (PGIO) is deciphering cancer’s ‘glyco code’ to pave the way for more precise diagnostics and next generation immunotherapies

Acquisition strengthens Roche’s digital pathology and companion diagnostic portfolio to advance precision medicine

New Sprint, Flex, and Flex+ packages deliver faster turnaround times, expanded vector options, and advanced codon optimization through a modern digital ordering experience

Expanded portfolio enables flexible panel design for flow cytometry and fluorescent western blot applications

New research‑use platform combines MSC cells and culture media to support immunology and regenerative medicine workflows

Explore advances in lab testing methods moving food allergy diagnosis beyond skin pricks and into molecular precision

Collaboration integrates LucentAD Complete into AI‑driven clinical workflows to support earlier detection and treatment decisions

Due to remarkable advances in genetic sequencing technology, researchers now have an abundance of tools at their disposal. From first-generation Sanger sequencing to next-generation or massively parallel sequencing, your choice of technique and technology must first and foremost complement your chosen application and help answer your specific research questions.

Approval by Japan’s MHLW enables use of MyChoice Test as a companion diagnostic for Lynparza in prostate cancer